Neuropathological correlates of amyloid PET imaging in Down syndrome
- 1 July 2019
- journal article
- review article
- Published by Wiley in Developmental Neurobiology
- Vol. 79 (7), 750-766
- https://doi.org/10.1002/dneu.22713
Abstract
Down syndrome (DS) results in an overproduction of amyloid-beta (A beta) peptide associated with early onset of Alzheimer's disease (AD). DS cases have A beta deposits detectable histologically as young as 12-30 years of age, primarily in the form of diffuse plaques, the type of early amyloid pathology also seen at pre-clinical (i.e., pathological aging) and prodromal stages of sporadic late onset AD. In DS subjects aged >40 years, levels of cortical A beta deposition are similar to those observed in late onset AD and in addition to diffuse plaques involve cored plaques associated with dystrophic neurites (neuritic plaques), which are of neuropathological diagnostic significance in AD. The purpose of this review is to summarize and discuss findings from amyloid PET imaging studies of DS in reference to postmortem amyloid-based neuropathology. PET neuroimaging applied to subjects with DS has the potential to (a) track the natural progression of brain pathology, including the earliest stages of amyloid accumulation, and (b) determine whether amyloid PET biomarkers predict the onset of dementia. In addition, the question that is still incompletely understood and relevant to both applications is the ability of amyloid PET to detect A beta deposits in their earliest form.Keywords
Funding Information
- National Institute on Aging (P01AG014449, P01AG025204, R01AG052528, R01AG061566, U01AG051406)
This publication has 136 references indexed in Scilit:
- Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodiesNeurobiology of Aging, 2012
- Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical studyActa Neuropathologica, 2012
- Positron Emission Tomography and Neuropathologic Estimates of Fibrillar Amyloid-β in a Patient With Down Syndrome and Alzheimer DiseaseArchives of Neurology, 2011
- In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB Positron Emission Tomography and Neuropathologic Assessment in Older AdultsArchives of Neurology, 2011
- Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s diseaseBrain, 2010
- In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementiaNeurology, 2010
- Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer’s diseaseActa Neuropathologica, 2009
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's diseaseBrain, 2008
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991